Chemfield Cellulose
Chemfield Cellulose is an Indian pharmaceutical excipient manufacturer founded in 1992, producing Microcrystalline Cellulose (MCC) products under the Chemicel® and Primecel® brands for global pharmaceutical manufacturers, with full regulatory compliance and value-added formulation services.
- Company typePrivate
- Founded1992
- HeadquartersNagpur, India
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Chemfield Cellulose does
Chemfield Cellulose Pvt. Ltd. is a Nagpur, India-based pharmaceutical excipient manufacturer founded in 1992, specializing in Microcrystalline Cellulose (MCC) production. The company operates a state-of-the-art manufacturing facility in MIDC Kalmeshwar (commissioned in 2013, designed by NNE Pharmaplan) that uses acidic hydrolysis of specialized wood pulp followed by spray drying via fully closed and automated processes. Its product portfolio includes two core brands: Chemicel® (standard MCC grade, launched in 2000, available in grades 101, 102, 102LM, 112, 301, 302, 103, and 200) and Primecel® (premium patented MCC launched in 2016, featuring extreme lot-to-lot consistency and minimal dark particles, available in grades 101, 102, and 200). Chemfield was the first manufacturer of spray dried MCC in India (since 1993) and the first MCC manufacturer globally to achieve EXCiPACT certification. The company supplements product sales with regulatory services offering formulation development, technology transfer, regulatory filing, analytical method validation, and stability testing for oral solid dosage and liquid/semisolid forms.
The company sells to multinational and domestic pharmaceutical manufacturers through a combination of direct sales (India) and a global distributor network covering Germany (Harke Pharma), Iran (Sabahi Enterprises), Russia (Protek SVM), Bangladesh (Top Rank), and USA (Biddle Sawyer Corporation). Named customers include GSK, Pfizer, Abbott, Wockhardt, Ajanta Pharma, Inventia, Sri Krishna, and Zim Labs. Pricing is quote-based B2B with multi-year contracts and standard packaging (25 kg HDPE bags with LDPE liners). The company participates in major trade shows including CPhI India, CPhI Worldwide, Vitafoods Europe, and Pharmatech. The company's go-to-market is enterprise field sales with substantial regulatory service support embedded in the customer relationship. As of March 11, 2025, Chemfield was acquired by Oji Holdings, a Japanese company, to strengthen its high-value-added pharmaceutical excipient business. Prior to the acquisition, Chemfield was part of Field Group, a family-run conglomerate with topline exceeding USD 50 million.
Chemfield Cellulose firmographics
Firmographics- Name
- Chemfield Cellulose
- Legal name
- Chemfield Cellulose Pvt. Ltd.
- Website
- https://chemfields.com
- Company type
- Private
- Founded year
- 1992
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Short description
- Chemfield Cellulose is an Indian pharmaceutical excipient manufacturer founded in 1992, producing Microcrystalline Cellulose (MCC) products under the Chemicel® and Primecel® brands for global pharmaceutical manufacturers, with full regulatory compliance and value-added formulation services.
- Ownership category
- akta.pro rank
Chemfield Cellulose industry classification
Industry- Product category
- Pharmaceutical Excipients (Microcrystalline Cellulose)
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Cellulose Derivatives (CMC, MCC, HPMC/MC; Cellulosic Thickeners) (AFAJABAH)
- akta.pro secondary industry
- Cellulose Derivatives (CMC, MCC, HPMC, MC) (AFAJAMAF)
Keywords
Where Chemfield Cellulose is headquartered
LocationHeadquarters
- HQ city
- Nagpur
- HQ country
- India
- HQ region
- Asia
Offices3 records
Markets served
Chemfield Cellulose business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure
Revenue model
- Pharmaceutical Excipient Sales: Sale of Microcrystalline Cellulose (MCC) products - Chemicel® and Primecel® - to pharmaceutical manufacturers for use as tablet binders and excipients in oral solid dosage formulations.
- Regulatory Services: Formulation development, technology transfer, regulatory filing, analytical method validation, sample analysis, stability testing and stability analysis services for OSD (tablets, capsules, sachets, granules, effervescent formulations) and liquids/semisolids.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Multi-year contract | Standard pharmaceutical excipient pricing based on product grade and order volume |
Go-to-market motion1 record
Distribution channels6 records
Marketing channels6 records
Chemfield Cellulose product offering
Product offeringCore offering
Chemfield Cellulose manufactures and sells Microcrystalline Cellulose (MCC) pharmaceutical excipients used as tablet binders and excipients in oral solid dosage formulations. Its core product line consists of the Chemicel® standard grade and the Primecel® super high-quality grade (with patented technology), available in multiple pharmacopeial grades (USP, Ph. EUR, BP, JP, IP), supplemented by formulation development and regulatory filing services for pharma customers.
Product overview
Chemfield Cellulose is a manufacturer of pharmaceutical excipients, specifically Microcrystalline Cellulose (MCC). The company operates a product portfolio consisting of two core MCC brands—Chemicel® (standard grade for domestic and Rest of World markets) and Primecel® (super high-quality grade with patented technology for regulated markets)—supplemented by Regulatory Services that provide formulation development and regulatory filing support. All MCC grades meet global pharmacopeia standards including USP, Ph. EUR, BP, JP and IP.
Differentiator
Problem solved
Functional benefit
Brands
- Chemicel®: First product launched by Chemfield - a value based and consistent MCC product, widely recognized and preferred choice for tablet manufacturing of top multinationals globally. Manufactured in various grades including 101, 102, 102LM, 112, 301, 302, 103, and 200.
- Primecel®
Products and services
- Chemicel® Chemfield's standard Microcrystalline Cellulose (MCC) excipient product, value-based and consistent, widely used as a tablet binder and diluent by top multinational pharmaceutical companies for oral solid dosage formulations. Available in multiple grades including 101, 102, 102LM, 112, 301, 302, 103, and 200 to meet specific customer requirements. Packaged in 25 kg HDPE bags with 2 inner LDPE liners; also available in 20 kg HDPE bags, paper bags, cartons, and 20/50 kg fiber drums.
- Primecel® Chemfield's premium, super high-quality Microcrystalline Cellulose (MCC) with patented technology, made from super specialized and extremely high-quality wood pulp combined with very tight in-process controls. Provides extreme lot-to-lot consistency and minimal or zero dark particles for superior functionality and quality requirements in regulated and quality-conscious pharmaceutical markets. Available in grades 101, 102, and 200.
- Ph-200 Microcrystalline Cellulose (MCC) product with advanced flowability characteristics, designed for oral solid dosage formulation applications where superior powder flow is required. Part of Chemfield's MCC grade portfolio.
- Regulatory Services Full-fledged regulatory service offering for research and formulation development of Oral Solid Dosage (OSD) forms including tablets, capsules, sachets, granules, and effervescent formulations, as well as liquids and semisolids. Services include formulation development, technology transfer, regulatory filing, analytical method validation, sample analysis, stability testing and stability analysis. Provided to pharmaceutical customers to support end-formulation development and filing requirements.
Quantifiable outcome
- First MCC manufacturer in India and first globally to achieve EXCiPACT certification
- +2 more outcomes
Companies that use Chemfield Cellulose
Customer profileNamed customers8 records
Segments1 record
Ideal customer profiles1 record
Chemfield Cellulose technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Chemfield Cellulose partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Abess HealthcarecoreStrategic partnership for continuous R&D and product development. Signed in June 2018, focused on new product development and formulation support for pharmaceutical excipients.
- Harke Pharma GmbHcoreExclusive distributor for Germany, headquartered in Muelhiem an der Ruhr. Represents Chemfield's MCC products (Chemicel® and Primecel®) in the German pharmaceutical market.
- Sabahi Enterprises Co.coreDistributor for Iran, headquartered in Tehran. Markets Chemfield's MCC products to Iranian pharmaceutical manufacturers.
- Protek SVM Ltd.coreDistributor for Russia, headquartered in Moscow. Also partnered with Chemfield for joint exhibition at Pharmatech trade shows in Russia.
- Top RankcoreDistributor for Bangladesh, headquartered in Dhaka. Markets Chemfield's MCC products to Bangladeshi pharmaceutical companies.
- Biddle Sawyer CorporationcoreDistributor for USA, headquartered in New York. Represents Chemfield's MCC products in the American pharmaceutical market.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Chemfield Cellulose competitors and assessment
Company assessmentBroad incumbents
- FMC Corporation - Health & Nutrition:
- Roquette: Roquette is one of the largest global suppliers of pharmaceutical excipients, including MCC and starch-based products, serving major pharma manufacturers worldwide. Comparable on pharmaceutical excipient category but with significantly broader portfolio.
- DuPont (now IFF) - Nutrition & Biosciences: DuPont's Nutrition & Biosciences (now part of IFF) is one of the world's largest producers of microcrystalline cellulose (brand: Avicel®) used as a pharmaceutical excipient. Direct product overlap with Chemfield's Chemicel® and Primecel® in the tablet binder market, with broader portfolio and scale.
Direct peers
- DFE Pharma: DFE Pharma is a specialized excipient manufacturer offering Pharmacel® (MCC) and other superdisintegrants/starches for oral solid dosage forms. Directly comparable as a focused pharmaceutical excipient supplier with similar product mix.
- JRS Pharma (J. Rettenmaier & Söhne): JRS Pharma is a leading manufacturer of cellulose-based pharmaceutical excipients including MCC (VIVAPUR®), competing head-to-head with Chemfield in tablet binder grades. Closely comparable on technology, customer base, and product portfolio focus.
- Asahi Kasei - Pharm Solutions: Asahi Kasei's Ceolus® brand is a globally recognized pharmaceutical-grade MCC competing with Chemicel® and Primecel® in regulated markets. Direct competitor with similar excipient-grade portfolio and global MNC pharma customer base.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Chemfield Cellulose social profiles
Digital presenceChemfield Cellulose compliance and trust
Trust signalCompliance3 records
Chemfield Cellulose financial estimates
Financial estimateRevenue estimate
Valuation estimate
Chemfield Cellulose leadership team
Management profileNumber of profiles
Profiles1 record
Chemfield Cellulose funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Chemfield Cellulose M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Chemfield Cellulose
What does Chemfield Cellulose do?
Chemfield Cellulose manufactures and sells Microcrystalline Cellulose (MCC) pharmaceutical excipients used as tablet binders and excipients in oral solid dosage formulations. Its core product line consists of the Chemicel® standard grade and the Primecel® super high-quality grade (with patented technology), available in multiple pharmacopeial grades (USP, Ph. EUR, BP, JP, IP), supplemented by formulation development and regulatory filing services for pharma customers.
Is Chemfield Cellulose a public or private company?
Chemfield Cellulose is a private company. It is classified as corporate owned and is currently acquired.
When was Chemfield Cellulose founded?
Chemfield Cellulose was founded in 1992. It employs 101 to 250 people.
Where is Chemfield Cellulose based?
Chemfield Cellulose is headquartered in Nagpur, India, in the Asia region.
How does Chemfield Cellulose make money?
Two revenue lines are on record. Pharmaceutical Excipient Sales are the primary driver. The others are regulatory Services.
Who are Chemfield Cellulose's main competitors?
Broad incumbents on record are FMC Corporation - Health & Nutrition, Roquette and DuPont (now IFF) - Nutrition & Biosciences. Direct peers are DFE Pharma, JRS Pharma (J. Rettenmaier & Söhne) and Asahi Kasei - Pharm Solutions.
Does Chemfield Cellulose have an API?
No public API is recorded for Chemfield Cellulose.
What industry is Chemfield Cellulose in?
Chemfield Cellulose's product category is Pharmaceutical Excipients (Microcrystalline Cellulose). Its primary akta.pro industry code is AFAJABAH, Cellulose Derivatives (CMC, MCC, HPMC/MC; Cellulosic Thickeners), with a secondary code of AFAJAMAF, Cellulose Derivatives (CMC, MCC, HPMC, MC). Its NAICS code is 32541 and its SIC code is 2833.